Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids

American Journal of Gastroenterology

Volumn 91, Issue 6, 1996, Pages 1266-1268

  Chalasani, N ^a   Gitlin, Norman ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRANCHED CHAIN AMINO ACID; LACTULOSE; NEOMYCIN;

ADULT; ARTICLE; BUDD CHIARI SYNDROME; CASE REPORT; COLON RESECTION; CONSERVATIVE TREATMENT; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN RESTRICTION; RECURRENT DISEASE;

ACUTE DISEASE; ADMINISTRATION, ORAL; AMINO ACIDS, BRANCHED-CHAIN; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HUMANS; MIDDLE AGED; RECURRENCE; TIME FACTORS;

EID: 0030006427     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hensen DM. Portal systemic encephalopathy and hepatic coma. Med Clin North Am 1986;70:1081-92.
2. Lockwood AH, McDonald JM, Reiman RE, et al. The dynamics of ammonia metabolism in man: Effects of liver disease and hyperammonemia. J Clin Invest 1979;63:449-60.
3. Ferenci P, Schafer DF, Kleinberger G, et al. Serum levels of gamma-amino butyric acid like activity in acute and chronic hepatocellular disease. Lancet 1983;2:811-4.
4. Muto Y. Clinical study on the relationship of short chain fatty acids and hepatic encephalopathy. Jpn J Gastrocnterol 1966;63:19-23.
5. Zieve L, Doizaki WM, Zieve FJ. Synergism between marcaptans and ammonia in the production of coma. A possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med 1974;83:16.
6. Iber FL, Rosen H, Levenson SM, et al. The plasma amino acids in patients with liver failure. J Lab Clin Med 1957;50:417-525.
7. Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971;2:75-80.
8. Siez A, Walker S, Czygan P, et al. Branched chain aminoacid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial. Z Gastroenterol 1983;21:644-50.
9. Morgan MY. Branched chain amino acids in the management of chronic liver disease: Facts and fantasies. J Hepatol 1990;11:133-41.
10. Marchesini G, Dioguardi FS, Bianchi GP, et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. J Hepatol 1990;11:92-101.
11. Naylor CD, O'Rourke K, Detsky AS, et al. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterol 1989;97:1033-42.
12. Eriksson LS, Conn HO. Branched-chain amino acids in the management of hepatic encephalopathy: An analysis of variants. Hepatology 1989;10:228-46.